Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis

ASV Shah, D Stelzle, KK Lee, EJ Beck, S Alam… - Circulation, 2018 - Am Heart Assoc
Background: With advances in antiretroviral therapy, most deaths in people with HIV are
now attributable to noncommunicable illnesses, especially cardiovascular disease. We …

The fat of the matter: obesity and visceral adiposity in treated HIV infection

JE Lake - Current HIV/AIDS Reports, 2017 - Springer
Abstract Purpose of Review The aim of this review is to summarize knowledge of the
prevalence, relevant physiology, and consequences of obesity and visceral adiposity in HIV …

Management of comorbidities in treated HIV infection: a long way to go: HIV, comorbidities and aging

J Martínez-Sanz, S Serrano-Villar, MJ Vivancos… - International Journal of …, 2022 - Elsevier
Modern ART has now achieved the goal of maintaining HIV RNA suppression with minimum
drug-related toxicities. Indeed, in high-income settings, the main health issues in adult …

Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

E Bernal, JM Gómez, I Jarrín, A Cano… - JAIDS Journal of …, 2018 - journals.lww.com
Background: The objective of this study was to investigate the long-term impact of low-level
viremia (LLV) on all-cause mortality, AIDS and non-AIDS events (NAEs), and virological …

Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort

YM Pacheco, I Jarrin, I Rosado, AA Campins… - Antiviral research, 2015 - Elsevier
The aim was to analyze clinical complications in HIV-infected subjects who persistently
maintain low CD4 levels despite virological response to cART in the Spanish CoRIS cohort …

Transgender women living with HIV frequently take antiretroviral therapy and/or feminizing hormone therapy differently than prescribed due to drug–drug interaction …

HM Braun, J Candelario, CL Hanlon, ER Segura… - LGBT health, 2017 - liebertpub.com
Purpose: Both hormone therapy (HT) and antiretroviral therapy (ART) can be lifesaving for
transgender women (TW) living with HIV, but each has side effects and potential drug–drug …

The HIV care cascade: Japanese perspectives

A Iwamoto, R Taira, Y Yokomaku, T Koibuchi… - PLoS …, 2017 - journals.plos.org
Japan has been known as a low HIV-prevalence country with a concentrated epidemic
among high-risk groups. However, it has not been determined whether Japan meets the 90 …

Increased non‐AIDS mortality among persons with AIDS‐defining events after antiretroviral therapy initiation

AC Pettit, MJ Giganti, SM Ingle, MT May… - Journal of the …, 2018 - Wiley Online Library
Introduction HIV‐1 infection leads to chronic inflammation and to an increased risk of non‐
AIDS mortality. Our objective was to determine whether AIDS‐defining events (ADE s) were …

Serious Non-AIDS events: Immunopathogenesis and interventional strategies

DC Hsu, I Sereti, J Ananworanich - AIDS Research and Therapy, 2013 - Springer
Despite the major advances in the management of HIV infection, HIV-infected patients still
have greater morbidity and mortality than the general population. Serious non-AIDS events …

On the way to find a cure: Purging latent HIV-1 reservoirs

C Schwartz, S Bouchat, C Marban, V Gautier… - Biochemical …, 2017 - Elsevier
Introduction of cART in 1996 has drastically increased the life expectancy of people living
with HIV-1. However, this treatment has not allowed cure as cessation of cART is associated …